This biotechnology company develops fungal bioremediation solutions to break down per- and poly-fluoroalkyl substances (PFAS) in contaminated soil. Their scalable biological compounds leverage specific fungal species to degrade pollutants, offering an eco-friendly method for environmental restoration.
Funding
Funding not disclosed
Founders
Product
Problem
Per- and poly-fluoroalkyl substances (PFAS) contaminate soil and water, posing significant environmental and health risks due to their persistence and bioaccumulation. Traditional remediation methods are often expensive, energy-intensive, and can generate secondary pollutants. There is a need for cost-effective and sustainable solutions to degrade these "forever chemicals" in situ.
Solution
Myconaut develops fungal-based bioremediation technologies to address PFAS contamination in soil. Their approach leverages the natural metabolic capabilities of specific fungal species to break down carbon chains, including PFAS compounds. By carefully collecting and analyzing soil samples, Myconaut identifies and optimizes fungal strains for enhanced pollutant degradation. The company is also exploring the use of AI to analyze complex environmental data and optimize their bioremediation approaches.
Target Audience
Myconaut's primary customers include environmental engineering firms, private landowners, public institutions, and government agencies seeking sustainable and cost-effective solutions for PFAS remediation.
Features
- Utilizes fungal bioremediation to degrade PFAS and other carbon-based pollutants
- Engages in ongoing research to explore fungal species interaction with pollutants
- Employs soil sample collection and analysis to inform the bioremediation process
- Developing AI tools to analyze environmental data and optimize fungal bioremediation
- Collaborates with universities and environmental engineering firms to advance research and development